National Hospital Organization Sagamihara National Hospital

Sagamihara, Kanagawa 252-0392

1 studies enrolling now · 5 studies all time

What they study most

Atopic Dermatitis, Eczema, Moderate Psoriasis, Plaque Psoriasis, Psoriasis, Psoriasis (PsO), Rheumatoid Arthritis, Severe Psoriasis, Urothelial Cancer

Studies at this site

• A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Enrolling by invitation
• Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis — Running, not enrolling
• A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) — Completed
• Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis — Completed
• A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). — Completed